Cannabis Law Report

AUGUST 27, 2021

ACS Laboratory Will Grant its Safety Seal to Any Product Testing Beyond the Minimum for a Full Panel of Tests. 24, 2021 /PRNewswire/ — ACS Laboratory , the largest state-of-the-art testing facility in cannabis and hemp testing in the eastern U.S., BOCA RATON, Fla. , Aug. BOCA RATON, Fla. , Aug.

Cannabinoids 98

Cannabinoids Programs Safety Hemp 98

Cannabis Law Report

JUNE 15, 2021

Drug Enforcement Administration-McAlester Resident Office and DEA Denver. The investigation was initiated by the DEA Denver office’s “Front Range Task Force” after a Chinese money laundering organization was identified that sold black market marijuana “to fund and further their criminal activities,” the sheriff office stated.

DEA 66

DEA Concentrates Safety Marijuana 66

Medicinal Genomics

FEBRUARY 8, 2023

The CannMed 23 Innovation and Investment Summit is a cannabis industry event like no other. Set at the beautiful Marriot Marco Island Resort, CannMed 23 provides an immersive forum where cannabis researchers, physicians, patients, entrepreneurs, and investors can collaborate and share their latest innovations and insights.

Wellness and Beauty 52

Wellness and Beauty Events Topical Safety 52

Veriheal

AUGUST 31, 2020

Add onto that the difficulty of these unprecedented times, as a minority-owned business, we’re making it our priority to pay it forward and invest in the future leaders of cannabis who will break barriers and pave the way for innovation in this burgeoning industry. . Veriheal’s Innovation in Cannabis Scholarship 2020 Winners .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

MAY 29, 2022

8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. To mitigate safety risks, FDA implemented a Risk Evaluation and Mitigation Strategy (REMS) with elements to assure safe use (ETASU) whereby patients self-administer the spray in their healthcare provider’s office under medical supervision.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

SpeedWeed

MARCH 21, 2021

With all the buzz surrounding Delta-8-tetrahydrocannabinol (THC) in the cannabis industry, many questions circulate around what the up-and-coming cannabinoid is, where it comes from, and its legal status. It produces some psychotropic effects that are less potent than Delta-9, the primary form of THC found in cannabis.

THC 52

THC Business DEA Cannabinoids 52

SpeedWeed

MARCH 17, 2021

With all the buzz surrounding Delta-8-tetrahydrocannabinol (THC) in the cannabis industry, many questions circulate around what the up-and-coming cannabinoid is, where it comes from, and its legal status. It produces some psychotropic effects that are less potent than Delta-9, the primary form of THC found in cannabis.

DEA 52

DEA Cannabinoids Research and Development THC 52

Cannabis Law Report

OCTOBER 31, 2019

The Oregon State Police (OSP) Northwest Region Marijuana Team executed a search warrant at a property near Dexter, which resulted in the confiscation of approximately 216 pounds (100,000mL) of cannabis extracts, two butane hash oil extraction machines valued at $120,000, as well as ten firearms. See the OSP press release.

Oil 45

Oil Extraction Hash Marijuana 45

Cannabis Law Report

JULY 9, 2021

Patients would participate in therapy sessions to prepare for the use of psychedelics, after which the substances would be administered under the guidance and supervision of trained medical professionals. Right to Try laws permit patients with serious or life-threatening diseases to access drugs that do not yet have government approval.

Law 105

Law Therapy Clinical Trials Research and Development 105

PrestoDoctor

FEBRUARY 6, 2023

Are you interested in using medical marijuana or medical cannabis? Other states have a list of qualifying conditions that the patients must meet to get an MMJ. Finally, you will complete the application and get charged for your appointment (patients only pay if approved!). Your patient status remains confidential.

Marijuana 52

Marijuana Patients Conditions Access 52

Cannabis Law Report

JUNE 4, 2021

is an industry innovator who has been involved in the growth of many companies in the cannabis industry, and started his relationship with Medical Marijuana Inc. Titus has been involved in the development and investment of several industry-leading cannabis and industrial hemp businesses during his most recent career.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

Cannabis Law Report

SEPTEMBER 23, 2021

Tracking recent data from within the last year (following the publication of the DEA Interim Final Rule which added confusion to the delta-8 legality question), more than a dozen hospital or emergency room visits and hundreds of calls to poison control were reported. Delta-8 THC products should be kept out of the reach of children and pets.

THC 52

THC Concentrates Pets DEA 52

Cannabis Law Report

APRIL 21, 2022

Publication of this process establishes “prior art,” contributing to MAPS’ patient access strategy by making intellectual property public . 30,000 patient doses) of MDMA in a four-step process beginning with a non-controlled starting material. The safety and efficacy of MDMA-assisted therapy is currently under investigation.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

PrestoDoctor

JULY 16, 2019

Cannabis is just one case that represents the uphill battle it takes to overcome misinformation, fear, and even the hatred of groups of people, to gain sensible legislation. The gains created so far are largely credited to the work of cannabis reform groups. Prominent Cannabis Reform Groups in America and Beyond.

Policy 40

Policy DEA Access Media 40

PrestoDoctor

JULY 16, 2019

Cannabis is just one case that represents the uphill battle it takes to overcome misinformation, fear, and even the hatred of groups of people, to gain sensible legislation. The gains created so far are largely credited to the work of cannabis reform groups. Prominent Cannabis Reform Groups in America and Beyond.

Policy 40

Policy DEA Access Media 40

CannaMD

SEPTEMBER 15, 2020

Current Florida medical marijuana patient? MORE DETAILS: On June 16, 2014, Florida became the 22nd state to legalize (at least partial) access to medical marijuana when Governor Rick Scott signed the Compassionate Medical Cannabis Act of 2014. Qualified patient. Thinking about getting your card? What about travel?

Law 126

Law Marijuana Patients Treatment 126

SpeedWeed

MARCH 21, 2021

With all the buzz surrounding Delta-8-tetrahydrocannabinol (THC) in the cannabis industry, many questions circulate around what the up-and-coming cannabinoid is, where it comes from, and its legal status. It produces some psychotropic effects that are less potent than Delta-9, the primary form of THC found in cannabis.

Research and Development 52

Research and Development Hydroponic DEA Cannabinoids 52

The Cannigma

JULY 3, 2023

Moreover, since both cannabis and MDMA are on their way to either descheduling, decriminalization or legalization around the world, this number is likely to grow. A whopping 95% of people who use MDMA/ecstasy also consume cannabis. Nearly 1% of Americans over the age of 12 have used MDMA in the past 12 months. That’s around 2.5

Research and Development 46

Research and Development Environment THC Microdosing 46

Cannabis Law Report

NOVEMBER 11, 2021

On November 3, 2021, New York’s Cannabis Control Board (CCB) held its third public meeting during which it made additional progress in developing the regulatory landscape contemplated by the Marijuana Regulation and Taxation Act (MRTA). the component responsible for the ‘high’ people may experience from using cannabis).”

Programs 52

Programs Hemp Supply Chain Seed-To-Sale 52

SpeedWeed

MARCH 18, 2021

Preliminary results from a long-awaited study indicate that cannabis appears to be a safe and well-tolerated treatment for patients managing post-traumatic stress disorder (PTSD), although researchers did not find strong signals of effectiveness. One group self-administered cannabis with 12% THC over three weeks.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

PrestoDoctor

JANUARY 14, 2020

For individuals who need marijuana or cannabis for medical reasons, they must get an MMJ. Other states have a list of conditions that the patients must meet to get an MMJ. government Tribal identification card approved by the Oklahoma Department of Public Safety for identification. Your patient status remains confidential.

Marijuana 52

Marijuana Patients Conditions Programs 52

PrestoDoctor

JANUARY 14, 2020

For individuals who need marijuana or cannabis for medical reasons, they must get an MMJ. Other states have a list of conditions that the patients must meet to get an MMJ. government Tribal identification card approved by the Oklahoma Department of Public Safety for identification. Your patient status remains confidential.

Marijuana 52

Marijuana Patients Conditions Programs 52

Cannabis Law Report

FEBRUARY 28, 2022

Show More According to the Drug Enforcement Administration (DEA), Schedule I drugs have “no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse.” 10, 2019), [link] [ [link] ]. In 2017, the FDA designated MDMA a breakthrough therapy for PTSD.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Canna Law Blog

SEPTEMBER 6, 2023

The HHS news means that the country’s top health agency has finally conceded that cannabis has medical value, and isn’t a drug of abuse on par with fentanyl or heroin. If cannabis goes from a Schedule I to a Schedule III, the cannabis industry as we know it will forever change. if the plant is moved to Schedule III.

Research and Development 111

Research and Development DEA Marijuana Pharmaceutical 111

CannaMD

SEPTEMBER 10, 2020

Is it safe to continue cannabis-based therapies during pregnancy? In the mid-20th century era of “reefer madness,” the mainstream view on cannabis and pregnancy was clear: expecting mothers who used marijuana were considered ‘derelict’ and in some cases criminally negligent for the endangerment of their unborn child.

Marijuana 60

Marijuana Therapy Data THC 60

Canna Law Blog

MAY 7, 2020

At the same time, because of the federal illegality of cannabis, the federal government has routinely denied third party requests for further research in regards to its potential medical benefits, among other health and safety impacts. These cannabis products are used by researchers in the U.S.

DEA 70

DEA Research and Development Cultivation Supply Chain 70

Cannabis Law Report

JUNE 12, 2021

MONTEREY, CA – Biopharmaceutical Research Company (BRC), an active Drug Enforcement Administration (DEA) license holder, and CURE Pharmaceutical Holding Corp. CURE has established itself as a leader in the oral application of cannabis-derived treatments, and we know we’ll be able to bring a lot of value to patients together.”.

DEA 59

DEA Pharmaceutical Research and Development Compliance 59

Cannabis Law Report

NOVEMBER 2, 2021

Delta-8 THC is making big waves in the cannabis industry at the minute, but with warnings from the FDA and CDC , not to mention harrowing accounts from users , it’s clear there’s more going on with the novel cannabinoid than meets the eye. Testing for Safety: Are Impurities a Problem? Testing for Safety: Are Impurities a Problem?

THC 96

THC CBD Legalization Vaping 96

Veriheal

JUNE 23, 2022

The legalization of cannabis is opening many doors in states that are embracing it. The lack of effective tools to measure cannabis impairment accurately, in practice, encourages the criminalization of legal cannabis in states where a legal grey area exists. MMJ Patients Criminalized Despite Legality.

Consumption 104

Consumption Legalization Concentrates Patients 104

Canna Law Blog

MARCH 4, 2020

According to the Feds, ketamine is safer than cannabis (which is a Schedule I controlled substance). According to the FDA , “once the FDA approves a drug, healthcare providers generally may prescribe the drug for an unapproved use when they judge that it is medically appropriate for their patient.”

Therapy 88

Therapy Legalization Chronic Pain DEA 88

Cannabis Law Report

JUNE 10, 2021

(OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has signed a partnership agreement with Biopharmaceutical Research Company , (BRC), an active Drug Enforcement Administration (DEA) license holder, to produce federally-compliant cannabis-based medical products.

Pharmaceutical 75

Pharmaceutical DEA Research and Development THC 75

Cannabis Law Report

MAY 24, 2022

Defendant and respondent Oakland Cannabis Buyers’ Cooperative created a medical dispensary that would serve eligible patients. Substances considered to pose the greatest risk to the public health and safety are subject to the most stringent controls and sanctions.

DEA 52

DEA History Medicine Marijuana 52

Canna Law Blog

MARCH 4, 2020

According to the Feds, ketamine is safer than cannabis (which is a Schedule I controlled substance). According to the FDA , “once the FDA approves a drug, healthcare providers generally may prescribe the drug for an unapproved use when they judge that it is medically appropriate for their patient.”

Legalization 52

Legalization Therapy Chronic Pain DEA 52

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. of the global population uses cannabis annually, making it the most commonly used drug worldwide. It should be noted that cannabis and marijuana are not interchangeable terms. Executive Summary.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

JULY 1, 2021

Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries. Things have changed a little in the past twenty years, when the DEA gave some researchers permission to study limited amounts of certain psychedelics. POPLAR will publish original law and policy research.

Law 105

Law Research and Development Therapy DEA 105

Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. submitted his first DEA application to manufacture marijuana for use in medical research.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

The Cannigma

MAY 6, 2021

Because most delta-8 products are derived from hemp plants, it is believed by some that they fall under a loophole in federal cannabis laws. The cannabis plant can produce a great number of active compounds — those unique to cannabis are called cannabinoids. It is also touted as natural and safe. What is delta-8-THC.

THC 145

THC Cannabinoids Concentrates Hemp 145